⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Phenelzine

فنلزین

⚠ Unverified

🧠 Nervous SystemMAO inhibitor (non-selective)

🤰 Pregnancy:Use with caution 👶 Children:Dangerous / avoid 👴 Older adults:Use with caution 🇮🇷 Not found in Iran list ⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA011909 ATC N06AF03

Market / country: 🇺🇸 USA

Nardil (US)

🧮 Dose calculator

Disease / regimen

Major depressive disorder · Regimen source: FDA Nardil · Dosage and Administration

• Increase fairly rapidly to at least 60 mg/day; up to 90 mg/day if needed. Response may take 4 weeks at 60 mg. Maintenance as low as 15 mg daily or every other day, reduced slowly. FDA Nardil · Dosage and Administration

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Hypersensitivity; pheochromocytoma; congestive heart failure; severe renal impairment or renal disease; history of liver disease or abnormal liver tests; sympathomimetic drugs (amphetamines, cocaine, methylphenidate, dopamine, epinephrine…) and high-tyramine foods (hypertensive crisis). FDA Nardil · Contraindications

Warnings

• Boxed warning: suicidality with antidepressants in children, adolescents and young adults. FDA Nardil · Warnings

Formulations

15 mg tablet — tablet 🇺🇸 USA FDA Nardil · How Supplied

👥 Special populations

🤰 PregnancyUse with caution
Darooyab: category C — only if benefit outweighs risk. Darooyab · G-605/Phenelzine-Sulfate — مصرف در بارداری
“مصرف در بارداری فنلزین سولفات گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:”
🤱 BreastfeedingNo data
The source for this drug has no section for this group.
👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Nardil · Boxed Warning
“Nardil is not approved for use in pediatric patients.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Nardil · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)NDA011909
DailyMed (FDA label)FDA Nardil
MedlinePlus (NIH)Phenelzine
WHO ATC/DDDN06AF03
Darooyab (Iran)Phenelzine-Sulfate

🇮🇷 Not found in Iran list Darooyab · G-605/Phenelzine-Sulfate

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Nardil · How Supplied FDA Nardil · Dosage and Administration FDA Nardil · Contraindications FDA Nardil · Warnings FDA Nardil · Boxed Warning FDA Nardil · Geriatric Use FDA Nardil · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-605/Phenelzine-Sulfate Darooyab · G-605/Phenelzine-Sulfate — مصرف در بارداری
Clinical review⚠ Unverified

🔗 Similar drugs

Same class

Tranylcypromine